The FDA is allowing MMI to enroll more patients in a feasibility trial studying use of the Symani robot for microsurgery to ...
Researchers found that individuals exposed to sugar restriction from pregnancy through roughly age 2 had a 46 percent lower ...
For decades, the WABC newscaster encouraged other families facing the disease to hold onto hope. Now, he finds himself ...
Bipartisan legislation would require insurers to cover FDA-approved medications that significantly slow disease progression, ...
The 76-year-old journalist went public with his diagnosis last month, saying his first symptom was “forgetting people’s names ...
Laredo dementia specialist Jose Angel Hernandez wrote a children's book to help families discuss Alzheimer's disease with ...
A protein that is a hallmark of Alzheimer’s disease may also ID a brain condition associated with head trauma in contact ...
Hopes that the first drugs shown to slow Alzheimer’s disease could be rolled out on the NHS have risen after a second manufacturer entered price negotiations. US drugmaker Eli Lilly and Company, which ...
2hon MSN
Newly identified mitochondrial plaques provide potential therapeutic target for Alzheimer's disease
Alzheimer's disease is a devastating neurodegenerative disorder affecting millions of people worldwide. Scientists have long ...
Researchers have uncovered a possible biological pathway connecting obesity to Alzheimer’s disease. Obesity appears to raise levels of certain fat molecules that can travel to the brain, disrupt its ...
Content oversight provided by Studio 1847 Alzheimer’s disease reshapes families and demands immense resilience. Yet a growing wave of scientific optimism is changing approaches to brain health. Local ...
Initially, Alzheimer’s tends to affect your learning and memory more than other types of dementia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results